Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Bio-Techne Corporation (TECH) 53rd Annual Nasdaq Investor Conference December 9, 2025 4:30 AM ESTCompany ParticipantsKim Kelderman - CEO, President ...

The global market is estimated at USD 25,900.5 million in 2025 and is forecast to reach USD 64,187.5 million by 2035, ...

McMaster University is expanding its nuclear training programs to prepare engineers, researchers, and medical specialists to ...

dA new article published in the Journal of Dental Research explores the development of an integrated data-cleaning and ...

The company said Enterprise Express is aimed at companies with smaller teams that are looking to deliver a clear return on ...

Natural Gas Services Group, Inc. stands out with strong growth, solid financials, and 25-30% stock upside. Click here to read my latest analysis of NGS.

Utilities that provide natural gas to customers are investing in smart technologies to modernize their infrastructure. These ...

Federal regulators reshape path for one of the Gulf Coast’s largest LNG projects—with the decision influencing how construction unfolds.

Eli Lilly, Johnson & Johnson and Sanofi stay in focus as Big Pharma shows signs of recovery amid innovation, M&A and easing ...

Expanding applications of genomics, proteomics, transcriptomics, and metabolomics accelerate clinical development, with North America leading and Asia Pacific emerging as the fastest-growing ...